NCT00373412View on ClinicalTrials.gov

Trial of pDNA CMV Vaccine (VCL-CT02) Followed by Towne CMV Vaccine (Towne) Challenge

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

February 29, 2008

Conditions
Cytomegalovirus Infection
Interventions
BIOLOGICAL

VCL CT02 pDNA vaccine

BIOLOGICAL

Towne CMV vaccine

Trial Locations (1)

94110

UCSF Positive Health Program, 995 Potrero, 4th Floor, San Francisco

Sponsors

Collaborators (1)

Vical
All Listed Sponsors
collaborator

Vical

INDUSTRY

lead

University of California, San Francisco

OTHER

NCT00373412 - Trial of pDNA CMV Vaccine (VCL-CT02) Followed by Towne CMV Vaccine (Towne) Challenge | Biotech Hunter | Biotech Hunter